Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 428.65
-3.55 (-0.82%)
May 29, 2026, 3:30 PM IST
Biocon Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Biocon stock has a consensus rating of "Buy" and an average price target of ₹416.55. The average 1-year stock price forecast is 2.82% lower than the current stock price, while the lowest is ₹290.00 (-32.35%) and the highest is ₹550.00 (+28.31%).
Price Target: ₹416.55 (-2.82%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 17, 2026.
Analyst Ratings
The average analyst rating for Biocon stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 9 | 9 | 8 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 3 | 3 | 4 | 4 | 4 | 5 |
| Strong Sell | 3 | 2 | 0 | 1 | 1 | 1 |
| Total | 20 | 20 | 19 | 19 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Axis Direct No rating | Axis Direct | Buy Maintains ₹435.00 | Buy | Maintains | ₹435.00 | +1.48% | Feb 17, 2026 |
| Geojit Research | Geojit Research | Buy Upgrades ₹312.00 → ₹439.00 | Buy | Upgrades | ₹312.00 → ₹439.00 | +2.41% | Jan 2, 2026 |
Unknown Analyst ICICI Securities No rating | ICICI Securities | Sell Downgrades ₹380.00 → ₹350.00 | Sell | Downgrades | ₹380.00 → ₹350.00 | -18.35% | Dec 10, 2025 |
Unknown Analyst Motilal Oswal No rating | Motilal Oswal | Buy Maintains ₹460.00 | Buy | Maintains | ₹460.00 | +7.31% | Dec 8, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.